RLAY
Relay Therapeutics·NASDAQ
--
--(--)
--
--(--)
RLAY fundamentals
Relay Therapeutics (RLAY) released its earnings on Feb 26, 2026: revenue was 7.00M (YoY --), beat estimates; EPS was -0.32 (YoY +28.89%), beat estimates.
Revenue / YoY
7.00M
--
EPS / YoY
-0.32
+28.89%
Report date
Feb 26, 2026
EPS
Actual | -6.06 | 0.36 | -0.47 | -2.1 | -0.66 | -0.59 | -0.57 | -0.71 | -0.76 | -0.56 | -0.78 | -0.81 | -0.54 | -0.67 | -0.62 | -0.69 | -0.63 | -0.45 | -0.46 | -0.41 | -0.43 | -0.32 |
Forecast | -0.3767 | 0.1683 | -0.4857 | -0.4486 | -0.612 | -0.5589 | -0.6183 | -0.6271 | -0.7056 | -0.7022 | -0.6912 | -0.8155 | -0.825 | -0.7182 | -0.7268 | -0.7327 | -0.7719 | -0.5612 | -0.4893 | -0.4918 | -0.4153 | -0.4046 |
Surprise | -1508.71% | +113.90% | +3.23% | -368.12% | -7.84% | -5.56% | +7.81% | -13.22% | -7.71% | +20.25% | -12.85% | +0.67% | +34.55% | +6.71% | +14.69% | +5.83% | +18.38% | +19.81% | +5.99% | +16.63% | -3.54% | +20.91% |
Revenue
Actual | 0 | 82.65M | 952.00K | 844.00K | 666.00K | 567.00K | 419.00K | 365.00K | 344.00K | 253.00K | 226.00K | 119.00K | 25.20M | -4.00K | 10.00M | 0 | 0 | 0 | 7.68M | 700.00K | 0 | 7.00M |
Forecast | 0 | 36.67M | 3.39M | 6.67M | 107.14K | 3.84M | 166.67K | 2.08M | 1.80M | 271.43K | 128.00K | 741.67K | 374.55K | 581.82K | 120.00K | 88.89K | 88.89K | 6.08M | 14.29K | 75.00K | 160.00K | 4.97M |
Surprise | 0.00% | +125.42% | -71.93% | -87.34% | +521.60% | -85.23% | +151.40% | -82.48% | -80.89% | -6.79% | +76.56% | -83.96% | +6628.70% | -100.69% | +8233.33% | -100.00% | -100.00% | -100.00% | +53651.93% | +833.33% | -100.00% | +40.96% |
Earnings Call
You can ask Aime
Did Relay Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Relay Therapeutics's revenue and profit?What were the key takeaways from Relay Therapeutics’s earnings call?What guidance did Relay Therapeutics's management provide for the next earnings period?What is Relay Therapeutics's gross profit margin?What is Relay Therapeutics's latest dividend and current dividend yield?What does Relay Therapeutics do and what are its main business segments?What were the key takeaways from Relay Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
